Cargando…
CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response
Inhibition of the chemokine receptor CXCR4 in combination with blockade of the PD-1/PD-L1 T cell checkpoint induces T cell infiltration and anticancer responses in murine and human pancreatic cancer. Here we elucidate the mechanism by which CXCR4 inhibition affects the tumor immune microenvironment....
Autores principales: | Biasci, Daniele, Smoragiewicz, Martin, Connell, Claire M., Wang, Zhikai, Gao, Ya, Thaventhiran, James E. D., Basu, Bristi, Magiera, Lukasz, Johnson, T. Isaac, Bax, Lisa, Gopinathan, Aarthi, Isherwood, Christopher, Gallagher, Ferdia A., Pawula, Maria, Hudecova, Irena, Gale, Davina, Rosenfeld, Nitzan, Barmpounakis, Petros, Popa, Elizabeta Cristina, Brais, Rebecca, Godfrey, Edmund, Mir, Fraz, Richards, Frances M., Fearon, Douglas T., Janowitz, Tobias, Jodrell, Duncan I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682333/ https://www.ncbi.nlm.nih.gov/pubmed/33127761 http://dx.doi.org/10.1073/pnas.2013644117 |
Ejemplares similares
-
GEMMs as preclinical models for testing pancreatic cancer therapies
por: Gopinathan, Aarthi, et al.
Publicado: (2015) -
Carcinomas assemble a filamentous CXCL12–keratin-19 coating that suppresses T cell–mediated immune attack
por: Wang, Zhikai, et al.
Publicado: (2022) -
Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes
por: Connell, C. M., et al.
Publicado: (2017) -
Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA
por: Hudecova, Irena, et al.
Publicado: (2022) -
Correlating Radiomic Features of Heterogeneity on CT with Circulating Tumor DNA in Metastatic Melanoma
por: Gill, Andrew B., et al.
Publicado: (2020)